URMC »Research » Research@URMC » September 2013

September 2013

Lab Pinpoints New Drug Target for Infant Leukemia

Although many childhood leukemias are curable, one type – known as 11q23 infant leukemia – has a poor survival rate and requires intensive treatment with life-threatening side effects. In an early-edition article in Blood, the URMC shows it discovered a gene that could provide a new target for therapy.

9/10/2013 | 1 comment